U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT06931327) titled 'To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C711 in Healthy Adults' on April 09.
Brief Summary: To evaluate the safety and pharmacokinetic characteristics of AJU-C711 in healthy adults
Study Start Date: March 29
Study Type: INTERVENTIONAL
Condition:
Hypercholesterolemia
Intervention:
DRUG: AJU-C711
Pitavastatin calcium 4mg, Ezetimibe 10mg
DRUG: C711R
Pitavastatin calcium 4mg, Ezetimibe 10mg
Recruitment Status: RECRUITING
Sponsor: AJU Pharm Co., Ltd.
Published by HT Digital Content Services with permission from Health Daily Digest....